$42.64
0.791.88%
Last update: Oct 9, 8:00 PM
As of Sep 15, 2026
Number of Stock Holdings
68
Number of Bond Holdings
-
Total Holdings
70
Number of ETFs
-
Franklin Genomic Advancements ETF (BATS: HELX)
The HELX ETF is currently trading at $42.64, which represents a 1.88% change. Over the past 52 weeks, the ETF has traded as high as $45.58 and as low as $31.24.
The expense ratio of HELX is 0.50%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for HELX is 29.68M. This represents the total market value of the assets managed by the ETF.
HELX follows a Mid Cap Growth investment style.
The top holdings of HELX include: KRYS (5.75%), NTRA (8.81%), GH (9.29%), ADPT (4.38%), BBIO (3.32%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for HELX is currently not available.
